Speakers

Rick Siow Mong Goh

Department Director of Computing and Intelligence, A*STAR Institute of High Performance Computing

Dr. Rick Goh is the Director of Computing & Intelligence Department at A*STAR’s Institute of High Performance Computing (IHPC), an Adj. Assoc. Professor at Duke-NUS Medical School, Adj. Senior Principal Investigator at Singapore Eye Research Institute (SERI), Co-Director of both A*STAR-EVYD Joint Lab and SERI-IHPC Joint Lab. He chaired the organising committee of HPC AI Innovation Challenge 2023-2024, organised by National Supercomputing Centre (NSCC), AI Singapore (AISG), and Infocomm Media Development Authority (IMDA).

Leading a team of 80 scientists and engineers, Dr. Goh focuses on world-leading scientific research, advancing technology commercialisation, and fostering industry collaborations. His dept specialises in Artificial Intelligence & Advanced Computing, including high performance computing using GPUs, FPGAs, quantum technologies, and decentralised computing like blockchain, secure multi-party computation and privacy-preserving federated learning. He has published 150+ peer-reviewed papers in prestigious healthcare journals including Nature Aging, Nature Genetics, The Lancet Digital Health, and top-tier AI journals and conferences such as Nature Machine Intelligence, Nature Comms, IEEE TPAMI, TNNLS, TPDS, Cybernetics, TMI, AAAI, CACM, CVPR, IJCAI, and MICCAI.

Under his leadership, his dept has won multiple highly competitive AI Singapore Tech Challenge and Grand Challenge grants, best paper awards, Global Challenge for Safe and Secure LLMs 2024, Singapore Blockchain Innovation Challenge 2024, RePSS Challenge 2024, and Singapore Healthcare Management Awards. His dept has secured over S$45M in industry cash and in-kind contributions, trained 150 researchers now working in academia or industry, spun off a startup that raised S$26M in investments and created 30 jobs, deployed a telehealth solution that saved 6,000 hospital bed days resulting in S$6M in cost savings, and was recognised with the Singapore National Award (COVID-19) Commendation Medal.

Tien Yin Wong

Professor & Senior Vice Chancellor, Tsinghua Medicine and Vice Provost, Tsinghua University

Professor Tien Yin Wong is a physician-scientist-innovator and the Senior Vice-Chancellor of Tsinghua Medicine and Vice-Provost of Tsinghua University, China. He has worked and held senior leadership roles in Singapore and Australia, including at the National University of Singapore, SingHealth Duke-NUS Medical School, Singapore National Eye Centre, and University of Melbourne.

Prof Wong is a practicing retinal specialist, with a research portfolio on retinal diseases, ocular imaging, AI and digital technology. He has published >1,600 peer-reviewed papers (H-index >200, highly cited researcher 2020-2025), given >600 invited named, plenary and symposium lectures, and received >US$100 million in grant funding. Prof Wong has been recognized with multiple international awards, including Arnall Patz Medal (Macula Society), Jose Rizal Medal (Asia Pacific Academy of Ophthalmology) and Friedenwald Award (ARVO). He has received Singapore’s President’s Science and Technology Award. He is an elected international (foreign) member of the US National Academy of Medicine and the Australian Academy of Health and Medical Sciences. He is also an elected fellow of the UK Royal Society.

Robert Morris

Chief Technology Strategist and Head (Data, Science & Technology), MOH Office for Healthcare Transformation

Robert is the Chief Technology Strategist at MOHT, where he anchors the Data and Technology Enablers. He concurrently serves as Professor at the Yong Loo Lin School of Medicine, National University of Singapore, and as Executive Director of the SIngapore Medical FOundation AI model (SIMFONI) Programme under the Consortium for Clinical Research and Innovation, Singapore.

His current focus is on the application of computer and information sciences, including AI, to transform healthcare.

Until 2017, Robert led all of IBM Research’s Global Laboratories. Prior to that, Robert was also head of the IBM Almaden Research Center (Silicon Valley), where relational database technology and the disk drive were invented. During this time he led the creation of Services Science, research for IBM’s ThinkPad, and Storage Systems. Earlier he also led advanced systems research at TJ Watson Center (New York), including the Deep Blue chess machine, which defeated world champion Garry Kasparov in 1997.

He completed his PhD in Computer Science at the University of California, Los Angeles.

Vy Tran

President, Asia Pacific and Japan (APJ), Siemens Healthineers

Vy Tran is a healthcare leader with a broad range of experience in medtech, medical devices and oncology.

As the President of Asia Pacific and Japan (APJ), Vy is responsible for one of the fastest growing and dynamic regions in Siemens Healthineers. She leads a passionate team of more than 5,000 Healthineers with a strong purpose of pioneering breakthroughs in healthcare, for everyone, everywhere, sustainably.

Since becoming the commercial regional head in 2022, Vy has led several strategic and digital transformation initiatives with a laser focus to build a more patient and customer-centric organization that brings high value care through a broad portfolio of healthcare offerings that alleviates key disease burdens and increases access to care in Asia.

In addition, Vy is responsible for the strategy, P&L and market growth for APJ and a member of the Siemens Healthineers Global Leadership Committee. Vy also sits on the Board of Asia Pacific Medical Technology Association (APACMed) and US-India Strategic Partnership Forum.

Prior to Siemens Healthineers, Vy served in leadership roles at Varian including Chief Compliance Office where she led policy development and regulatory reform. She was also instrumental in sharpening Varian’s focus on becoming a leading cancer care company through strategic acquisitions, divestments and was involved in the combination of Varian and Siemens Healthineers in 2021.

Vy is passionate about bringing access and equity to patients and her personal mission of promoting diversity, equality and empowering people to reach their potential.

Vy holds a bachelor’s degree of Science from Santa Clara University and a Juris Doctorate from Lincoln Law School. In line with her interest in early childhood education, Vy is part of the Board of Directors for the Children’s Discovery Museum of San Jose and serves as the Board Secretary.

Originally from Silicon Valley, Vy lives in Singapore, with her husband and two teenage daughters.

Chwee Teck Lim

Director, Institute for Health Innovation & Technology (iHealthtech), NUS

Professor Chwee Teck Lim is the NUSS Chair Professor and Director of the Institute for Health Innovation and Technology at the National University of Singapore. He is also the Founding Director of the Singapore Health Technologies Consortium, a national initiative. He conducts research in human disease mechanobiology and develops innovative medical technologies for healthcare applications. Prof Lim has co-authored over 500 journal articles and delivered over 550 invited talks. He is also a serial entrepreneur having cofounded six startups with one public listed in 2018. Prof Lim is globally recognised for his distinguished achievements by the over 100 research awards and honors including the Nature Lifetime Achievement Award for Mentoring in Science, Otto Schmitt Award, Highly Cited Researcher, Asia’s Most Influential Scientist Award, ASEAN Outstanding Engineering Achievement Award, Asian Scientists 100, Credit Suisse Technopreneur of the Year Award, Wall Street Journal Asian Innovation Award and the President's Technology Award. He is also an Elected Fellow of 9 academies including the UK Royal Society, US National Academy of Inventors, ASEAN Academy of Engineering and Technology, Singapore National Academy of Science, Academy of Engineering, Singapore and Institution of Engineers, Singapore among others.

Nigam H. Shah

Chief Data Scientist, Stanford Health Care, and Professor of Medicine, and of Biomedical Data Science, Associate Dean (School of Medicine), Associate Director (Stanford Center for Biomedical Informatics Research), Stanford University

Dr. Nigam Shah is Professor of Medicine at Stanford University and Chief Data Scientist for Stanford Health Care. He is a world-renowned scientist and entrepreneur with deep expertise in applying machine learning and artificial intelligence (AI) to analyze diverse health data, including electronic health records, claims, and wearables. In his Chief Data Scientist role, he oversees the responsible use of AI for advancing disease understanding and improving clinical care delivery across Stanford Health Care. In 2018, he created the USA's only bedside consultation service, to provide clinicians with on-demand patient outcome summaries. This service was cited in Congressional testimony and was spun out as the independent company Atropos Health in 2021.

Shah's research is highly influential, with over 350 publications (h-index 94) in journals such as JAMA and the New England Journal of Medicine, receiving over 43,000 citations. As an entrepreneur, he holds nine patents and co-founded three companies that collectively raised over $100 million. He is a dedicated educator, teaching in multiple graduate classes at Stanford University and in an AI in Healthcare Specialization to over 60,000 students online. He is a member of the National Academy of Medicine’s Digital Learning Collaborative as well as a cofounder of the coalition for health AI, which provides guidelines for the responsible use of AI in healthcare.

Martin Saerbeck

Founder & CTO, AIQURIS

Martin is a leading voice in AI assurance and systems design. As former CTO of TUV SUD Digital Service, he pioneered one of the first certification-ready models for AI through the TUV SUD AI Quality Framework. He holds a PhD in Computer Science, and his work spans robotics, IoT, and applied machine learning. As a contributor to ISO, IEEE SA, and DIN committees, Martin turns turning emerging standards into robust, real-world assurance systems.

Irene Cheong

Assistant Chief Executive (Innovation and Enterprise), Agency for Science, Technology and Research

Ms Irene Cheong is the Assistant Chief Executive, Innovation & Enterprise (I&E), at A*STAR. She provides operational leadership to the I&E Group and National Platforms and drives I&E's daily operations. She also leads A*STAR's industry engagements, catalysing more impactful A*STAR spin-offs and growing significant value in A*STAR's existing start-up portfolio.

Since joining A*STAR, Ms Cheong has led productisation and alignment efforts in MedTech, while putting in place strong programmes and partnerships to jumpstart A*STAR's venture building and spin-off capabilities. As Acting CEO, DxD Hub, Ms Cheong also oversees numerous collaborations with clinicians, scientists and companies to co-develop medically regulated diagnostics from early-stage biomarker validation through validation into regulatory and manufacturing. Ms Cheong holds core capabilities in biotech, medtech and diagnostics domains as well as industry development and venture creation.

Ms Cheong has prior experience in both the public, private sector and has proven herself to be strong in developing industry-academia partnerships across both the biomedical and physical sciences sectors. She founded and delivered on several noteworthy venture building programmes at the National University of Singapore (NUS), such as the Lean LaunchPad, JUMPStart and Graduate Research Innovation Programme (GRIP). She is experienced in developing start-up ecosystems and early-stage biotech and medtech investments, having been at EDB Investments based in San Francisco, and running sales and marketing for AstraZeneca based in Brussels and London. Prior to joining A*STAR, Ms Cheong helmed the Industry Liaison Office at NUS where she led technology commercialisation, industry collaborations and venture development programmes.

She is currently A*STAR's representative on numerous committees, including the steering committee for the NTU-NHG-A*STAR start-up space, co11ab, board oversight committee for Cardiovascular Disease National Collaborative Enterprise (CADENCE), SIP Joint Steering Committee and a council member of the Singapore-Jiangsu and Singapore-Guangdong Cooperation Councils, as well as selection committee member for the President's Technology Award, and MOE's IEOC Steering Committee.

Ms Cheong graduated with a Global Executive Master of Business Administration from NUS-UCLA, under a dual degree programme and a Master of Science, specialising in Microbiology. She also completed the Harvard Business School General Management Programme in 2023.

Michael Chee

Director, Centre for Sleep and Cognition, Yong Loo Lin School of Medicine, National University of Singapore

Professor Michael Chee, MBBS, FRCP(Edin) is the Director of Centre for Sleep and Cognition at the National University of Singapore Yong Loo Lin School of Medicine. He is a pioneer clinician-scientist in Singapore who has won the National Outstanding Clinician-Scientist Award (2009) and is a three-time award winner of the National Medical Research Council’s top tier Clinician-Scientist STaR award (2007, 2013, 2019). He is an inaugural Fellow of the Organisation for Human Brain Mapping.

As an esteemed Sleep Researcher, Professor Michael Chee’s work on sleep over the last 20 years has focused on characterising and alleviating the negative impact of sleep deprivation on cognitive performance, wellbeing and health using innovative cognitive tests as well as a wide range of instrumentation including EEG, MRI, wearable devices, and ecological momentary assessments. His team ran 5 editions of the adolescent ‘Need for Sleep Studies’ – a 2-week sleep camp investigating the effects of different doses of sleep on vigilance, memory and mood.

Renowned as a leading Sleep Researcher, he has led work on non-invasive stimulation technologies to enhance sleep, a series of intervention studies involving sleep education and starting school later to help adolescents sleep longer, developed smartphone apps to assess time use and to probe sleep and daytime wellbeing, as well as multiple papers investigating the neural mechanisms of sleep loss as well as the benefit of naps. His 200+ publications include contributions to Ann Rev Psychol, PNAS, Neuron, J Neuroscience, Am J Psychiatry, Neurology, Sleep and NeuroImage. His research has attracted over $50 million in funding as Principal Investigator.

In the sleep field, he has served as Vice President (2013-2014) and President (2016-2018) of the Singapore Sleep Society, given plenary or keynote talks at top conferences such as World Sleep, Organization for Human Brain Mapping and the American Academy of Sleep Medicine, consulted for AIA and presently sits on the editorial boards of Sleep, Imaging Neuroscience and Current Opinion in Behavioral Sciences.

He has also written numerous commentaries on sleep and public health and has appeared on television, internet, and international print media in relation to his advocacy work for sleep, which has been cited by the Times, Guardian, Economist, and other influential lay press publications. He has also trained over 80 research staff including 4 Associate Professors, 7 Assistant Professors, numerous research fellows as well as a few medical doctors, clinical psychologists, and founders of two tech start-ups.

Choon Hong Tay

Chief Executive Officer, Health Promotion Board

Mr Tay Choon Hong is the Chief Executive of the Health Promotion Board (HPB), which is part of the Ministry of Health in Singapore. HPB’s role is to empower individuals to take ownership of their health, towards its vision of a nation of healthy people. To achieve this, HPB works with a wide spectrum of 3P partners and stakeholders to build a supportive ecosystem that enables Singaporeans to engage in healthy lifestyle activities, and lead healthier lives.

Prior to this, Mr Tay was the Senior Director (Youth) in the Ministry of Culture, Community & Youth, and concurrently Deputy Chief Executive of the National Youth Council. He led the review of policies and programmes aimed at developing youths to be future-ready and committed to the nation. Mr Tay also served in the Public Service Division, where he oversaw the Public Sector Transformation change movement aimed at strengthening capabilities in innovation, collaboration, service delivery, employee engagement and citizen engagement.

Mr Tay previously served in the National Population and Talent Division, the Ministry of Manpower, and the Ministry of Home Affairs.

Mr Tay graduated from Carnegie Mellon University with dual Bachelor’s in Electrical and Computer Engineering, and Economics. He also holds a Master of Science in Management from the Stanford Graduate School of Business.

Wing Lok Au

Chief Executive Officer and Senior Consultant Neurologist, National Neuroscience Institute

Professor Au Wing Lok is the Chief Executive Officer of Singapore's National Neuroscience Institute (NNI) and a Senior Consultant Neurologist. After graduating from the National University of Singapore, he completed his specialist training at NNI before advancing his expertise through a two-year Movement Disorders Fellowship at Canada's Pacific Parkinson's Research Centre. He also received specialised training in electrophysiology (the study of electrical activity in the nervous system) at Toronto Western Hospital, Canada.

Assoc Prof Au sees patients at NNI@TTSH and specialises in treating patients with Parkinson's disease and various movement disorders. He is trained in administering botulinum toxin injections (medication injections that help relax overactive muscles) for conditions such as:

- Hemifacial spasm (involuntary twitching or contractions of facial muscles)

- Blepharospasm (uncontrollable blinking or closure of the eyes)

- Dystonia (sustained muscle contractions causing unusual postures or repetitive movements)

- Spasticity (continuous muscle stiffness and tightness)

His research focuses on functional neuroimaging (advanced brain scanning techniques) and electrophysiology in Parkinson's disease, working to better understand how the brain functions in patients with movement disorders.

As the leader of NNI, A/Prof Au believes that employee wellness is key so that staff can give their best to their patients. He received the WorkWell Leaders Wellbeing CEO Award 2025 for prioritising staff mental wellbeing and creating a more resilient and supportive workplace at NNI.

Joe Sim

Group Chief Executive Officer, NHG Health

Prof Joe Sim is the Group Chief Executive Officer (GCEO) of NHG Health, one of Singapore’s three public healthcare clusters comprising an integrated system of polyclinics, acute care and tertiary hospitals, and national specialty centres. Prof Sim oversees NHG Health’s strategies to improve access to and equity in healthcare through innovation, evidence-based research, technology and meaningful collaborations.

Before joining NHG Health, Prof Sim was the Group Chief Operating Officer and Acting GCEO of IHH Healthcare Berhad (listed in both Singapore Exchange and Bursa Malaysia) where he was responsible for its integrated healthcare businesses comprising more than 80 hospitals and multiple business units across 10 countries. He joined IHH in 2017 as the CEO of Malaysia Operations Division, overseeing operations and management for IHH’s business units in Malaysia covering a network of 15 Gleneagles and Pantai hospitals and ancillary services such as Pantai Integrated Rehab and Pantai Premier Pathology.

Prior to IHH, Prof Sim was Deputy Chief Executive of the National University Health System (NUHS), another public healthcare cluster in Singapore. Prof Sim graduated with First Class Honours in Bachelor of Arts in Electronic and Information Science from Cambridge University, and holds a Master in Public Administration from Harvard University.

Abel Ang

Adjunct Professor and Chairperson, Advanced MedTech Investments

Ang is the chairperson of Advanced MedTech Investments. Between 2014 and 2024, he led Advanced MedTech - Temasek Holding's US$335M global platform in urology devices and services. As Founding President and Group CEO, he transformed the carved-out medical device platform from a loss-making unit to a top performer (IRR-returns) within Temasek’s portfolio. He drove significant revenue growth by transforming the group’s product portfolio, achieving a 4-fold increase during his tenure, while simultaneously increasing EBITDA by 33 times without any additional capital from shareholders.

Ang boasts a proven track record of medtech innovation, having brought 100 distinct devices to market globally. He specializes in accelerating R&D productivity and scaling commercial organizations to extract maximum value from new product innovation, especially in the US. Advanced MedTech’s US revenue grew 10-fold during his tenure to US$200M with an annual growth-rate of 22.3% in 2024.

He served as Senior Advisor to the CEO of Greatbatch Inc. (NYSE: ITGR), supporting innovation across cardiac, neurology, vascular, and orthopedic markets. Prior to this, Ang led Hill-Rom Inc., a $3B medical device company (acquired by BAX), as President, Asia/Pacific. As Hill-Rom's Chief Technology Officer, he oversaw global R&D operations spanning the U.S., Mexico, France, and Singapore. He also held key leadership roles including Vice-President and General Manager of the $420M Global Therapy Business Unit and Vice-President for International M&A. He formerly headed the global Medical Technology and Biotechnology industry groups in the Singapore Economic Development Board (EDB).

Ang sits on the Board of Economic Development Innovations Singapore, a privately-held investment holding company headquartered in Singapore with investments in deeptech and listed assets. He sits on the Boards of Advanced MedTech Holdings, SonoMotion Inc., ABM Respiratory Inc., and Vivance(formerly AWAK Technologies), where he chairs the Board. He was formerly on the Board and Nominating Committee of Aslan Pharmaceuticals (NYSE: ASLN).

On the education front, Ang is an adjunct full-professor at the Nanyang Business School in Singapore and Waseda University in Japan, where he teaches in their respective MBA programs. He is Chairman of Republic Polytechnic and Vice-Chairman of Singapore Institute of Management that collectively have 30,000 full-time higher education students. Ang has a Master of Science in Computational Biology from Rutgers University in New Jersey, which he pursued while on an EDB scholarship. He attended Harvard Business School’s Advanced Management Program in 2012.

He was awarded the Public Service Medal (PBM) in 2021 for his contributions to the medical device industry in Singapore. He was again awarded the Public Service Medal (COVID-19) in 2022 for his innovative achievements during COVID.

Ang is married and has 2 grown boys. He writes a regular column in The Straits Times and wing-foils in his free time.

Joseph Mocanu

Managing Partner, Verge HealthTech

Dr. Joseph Mocanu is the co-founder and Managing Partner of Verge HealthTech Fund focusing on early-stage healthcare technology companies that make an impact on global health. Prior to this, Joseph was a scientist researching new cancer therapies, a medical device entrepreneur, and a management consultant for Oliver Wyman where he led life sciences and digital health across Asia. He has 19 scientific publications, 3 patents, and has made investments in 46 healthcare technology companies to date. Joseph has a PhD from the University of Toronto, and an MBA from the Richard Ivey School of Business.

Wai Hoe Ng

Group Chief Executive Officer, SingHealth

Professor Ng Wai Hoe is the Group Chief Executive Officer of SingHealth and Professor at Duke-NUS Medical School. He was previously Deputy Group Chief Executive Officer (Strategy & Planning) of SingHealth, Chief Executive Officer of Changi General Hospital (CGH), Medical Director/Chief Executive Officer of the National Neuroscience Institute (NNI), Academic Chair of the SingHealth Duke-NUS Neuroscience Academic Clinical Programme and Deputy Chair of the SingHealth Medical Board.

He has present and past administrative responsibilities as Member of the Duke-NUS Governing Board, Executive Committee Member of the National Medical Research Council (NMRC), Member of the Human Health Potential (HHP) Executive Committee of the National Research Foundation (NRF), Member of the Medical Device Advisory Committee (MDAC) with the Health Sciences Authority (HSA) Singapore, Member of the Medical Technology Advisory Council (MTAC) of the Ministry of Health (MOH), Co-Chairperson of the Workgroup to Review the Taking of Informed Consent and Singapore Medical Council Disciplinary Process with the MOH and Panel of Chairmen of Disciplinary Tribunal with the Singapore Medical Council (SMC).

His clinical practice focuses on neurosurgical oncology, epilepsy surgery and stereotactic and functional neurosurgery. He was past Chairman of the Neurosurgery Residency Advisory Committee (RAC) and past Chairman of the Chapter of Neurosurgeons (Singapore).

Kee Yuan Ngiam

Head, Artificial Intelligence Office, National University Health System

Prof Ngiam Kee Yuan is Head of the Artificial Intelligence Office, National University Health System. He is also Adjunct Professor at the Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore. In his clinical role, he is Head and Senior Consultant at the Division of General Surgery (Thyroid & Endocrine Surgery) at the National University Hospital, specialising in Thyroid and Endocrine surgical disorders. His special interests are in thyroid and endocrine surgery, robotic thyroid surgery, AI and technology implementation in healthcare.

Yong Liu

Deputy Director of Computing and Intelligence, A*STAR Institute of High Performance Computing

Dr Liu Yong is Deputy Department Director, Computing & Intelligence Department at Institute of High Performance Computing (IHPC), A*STAR, Singapore. He is also Adjunct Associate Professor at Duke-NUS Medical School, NUS and Adjunct Principal Investigator at Singapore Eye Research Institute (SERI).

Being passionate on the potential of AI on healthcare, he has led multiple research projects in multimodal machine learning, medical imaging analysis, especially AI for digital ophthalmology and other areas in healthcare. Together with clinicians, he has been awarded large scale programme and multiple grants as PI in the area of AI for healthcare. He and his team have been awarded multiple grants from AI SG, NMRC, IAF-PP, and NHIC. He and his team have also published top tier papers in New England Journal of Medicine, Lancet Digital Health, Nature Aging, Ophthalmology, Neurology, Annals of Neurology, and also top-tier AI papers (AAAI, CVPR, IJCAI, MICCAI). He has won the Nation Award (Covid-19) Commendation Medal. His papers received Best Paper Award at REMIA workshop with 2022 MICCAI, Best Paper Award at BeyondLabeler Workshop on International Joint Conference on Artificial Intelligence (IJCAI) 2016. He and his team has also won the 3rd Place GAMMA Challenge in MICCAI 2021, the NSCC Outstanding HPC Innovation Award 2017, and the first prize of Rakuten TV recommendation Challenge 2015.

Cher Heng Tan

Co-Chair, National AI Medical Imaging Platform (AimSG), Chief Medical Scientist, Centre of AI in Medicine (NTU), and Senior Consultant, Department of Diagnostic Radiology, Tan Tock Seng Hospital

A/Professor Cher Heng Tan graduated with MBBS (Singapore) and FRCR (UK). He completed his Abdominal Imaging Fellowship at MD Anderson Cancer Center, and thereafter, Executive MBA from Insead. He is presently Senior Consultant with the Department of Diagnostic Radiology at Tan Tock Seng Hospital and Chief Operating Officer at Woodlands Hospital. He had formerly served as Assistant Chairman Medical Board (Clinical Research and Innovation) and NHG Health’s Chief Research and Innovation Officer.

He is concurrently Assistant Dean (Clinical Research) for the Lee Kong Chian School of Medicine and is involved in the setting up of the Academic Health System between NHG and LKCMedicine-NTU Singapore, as Director of the joint Academic Partnerships Office.

Cher Heng currently leads NHG Health’s efforts in implementation of AI in Radiology as co-Chair for the national imaging AI platform (AimSG) and plays a bridging role with NTU as Chief Medical Scientist of its Centre of AI in Medicine.

Daria Lemann-Blumenthal

Chief Executive Officer, Nanodrops

Daria Lemann-Blumenthal is the CEO of NanoDrops, a MedTech company pioneering a breakthrough vision correction technology that eliminates the need for reading glasses. Prior to joining NanoDrops, Daria was the co-founder and CEO of BELKIN Vision, which was acquired by Alcon in 2024 for $466 million, after developing a laser-based glaucoma treatment. She previously served as the CEO of Ein Tal Eye Center, Israel's largest ophthalmic care facility, and led its acquisition. Daria has spent five years of her career in Canada and the USA. She holds an LLB from the Hebrew University of Jerusalem and an Executive MBA from Tel Aviv University, both awarded with Dean’s Honors.

Navjeewan Khosla

Partner, Novo Holdings

Nav joined Novo Holdings Asia in August 2021. He focusses on deal sourcing and execution as well as in managing and developing the growing portfolio of investments, focusing primarily on the markets in China, India, and Southeast Asia.

Prior to joining Novo Holdings Asia, Nav was a Director in Quadria Capital, a mid-market private equity firm focusing on healthcare investments in India and South East Asia. Before joining Quadria Capital, Nav was the Managing Director at Fosun, where he worked on both private and public healthcare investment opportunities across the Asia-Pacific region. Nav started his investment career with Merrill Lynch in Hong Kong and moved to UBS Global Asset Management in Singapore before joining Fosun.

Nav holds an MBA from Indian Institute of Management (IIM), Ahmedabad, in India and Bachelor of Technology from Indian institute of Technology (IIT), Kharagpur in India.

Lawrence Wee

Director, Business and Ecosystems, Infocomm Media Development Authority

Dr. Lawrence Wee is currently Director of the Business and Ecosystems division at IMDA. His team is responsible for driving strategic collaborations to catalyze the exploitation and adoption of AI and emerging technologies for enterprises.

He started his career in public sector research and development when he founded the Healthcare and Biomedical Analytics Laboratory at the Institute of Infocomm Research (I2R), which focused on building deep capabilities in machine learning for biomedicine and healthcare. After the stint at I2R, he moved on to Zuellig Pharma where he took on the role of Chief Data Scientist and led the development of institutional data science capabilities across APAC region. Following that, he joined Allianz Asia-Pacific, where he was responsible for building the regional APAC healthcare data science capabilities across life and health insurance business units. Thereafter, he returned to public service at the Ministry of Health where he had the opportunity to drive strategy and capability development in AI and emerging technologies for the public health sector.

He is an Associate Faculty at the Singapore University of Social Sciences, and was previously the President of the Association for Medical and Bio-informatics Singapore (AMBIS), and vice-chair of the Chinese-American Pharmaceutical Society (CABS) Singapore chapter.

He received his Ph.D. in Computational Biology from the National University of Singapore.

Rob Korom

Chief Medical Officer, Penda Health

Rob Korom, MD, is Chief Medical Officer of Penda Health, a tech-enabled network of primary care clinics in Kenya serving over 1,000 patients daily across Nairobi. He leads clinical quality, AI-driven decision support, and digital innovation to advance Penda’s mission of becoming the most trusted healthcare provider in Africa.

Kwok Ming Lee

Group Director (Ageing Planning Office), Ministry of Health

Mr. Lee Kwok Ming was appointed Group Director of the Ageing Planning Office in the Ministry of Health on 9 October 2023. He oversees the development and implementation of the national ageing agenda, to bring about the national vision of opportunities, communities and a city for all ages. This whole-of-government work spans a wide range of areas including Age Well SG, aged care services, senior housing, seniors health & wellness and ageing research & development.

Kwok Ming’s public service career started in 2008 at the Income Security Policy Division in the Ministry of Manpower. He was responsible for formulating policies, including those related to the Central Provident Fund (CPF), to enhance the retirement adequacy of Singaporeans. Following that he served in a succession of portfolios, including Reserves and Investment at the Ministry of Finance, Land Transport at the Ministry of Transport. In 2019, he returned to the Ministry of Manpower as the Director (Retirement Systems) at the Income Security Policy Division where he was driving projects such as strengthening basic work protections for Platform Workers as well as the development of the Majulah Package.

Kwok Ming graduated from Carnegie Mellon University with a B. Sci. Electrical & Computer Engineering with Additional Major in Economics. He also holds a M. Sci. in Management Science & Engineering from Stanford University and an MBA from INSEAD. Kwok Ming is married with a son and a daughter.